首页 | 本学科首页   官方微博 | 高级检索  
     

尿激酶股动脉溶栓治疗脑出血合并DVT研究
引用本文:吴克谅,衣美玉,杨华进,刘静,衣淑华,马秀妮,徐世叶. 尿激酶股动脉溶栓治疗脑出血合并DVT研究[J]. 实用全科医学, 2010, 8(5): 591-592
作者姓名:吴克谅  衣美玉  杨华进  刘静  衣淑华  马秀妮  徐世叶
作者单位:山东省栖霞市人民医院神经内科,265300 
摘    要:
目的研究高血压脑出血并DVT患者应用尿激酶股动脉溶栓联合低分子肝素皮下注射治疗的有效性和安全性。方法对60例患者分别采用尿激酶30万U患肢股动脉溶栓联合低分子肝素5000U每日1次皮下注射与单用低分子肝素治疗的疗效比较。结果治疗组7d、14d时的治愈率及7d时的总有效率与对照组比较差异有统计学意义(P〈0.01)。无脑出血加重、再出血及其它严重并发症的发生。结论尿激酶股动脉溶栓联合低分子肝素治疗高血压脑出血并DVT患者优于单用低分子肝素,安全有效,降低了肺栓塞和慢性深静脉功能不全的发生。

关 键 词:尿激酶  低分子肝素  溶栓治疗  高血压脑出血  下肢深静脉血栓  股动脉

Femoral Artery Thrombolysis with Urokinase Combined Low Molecular Weight Heparin in the Treatment of Hypertensive Cerebral Hemorrhage Accompanied with Lower Extremity Deep Vein Thrombosis
Affiliation:WU Ke-liang,YI Mei-yu,YANG Hua-jin,et al.Department of Neurology,the People’s Hospital of Qixia,Qixia 265300,Shandong,China
Abstract:
Objective To investigate the efficacy and safety of treatment of hypertensive intracerebral hemorrhage and deep vein thrombosis of lower extremity(DVT)patients with femoral artery thrombolysis and urokinase combined subcutaneous low molecular weight heparin treatment.Methods The patients were treated with urokinase and low molecular weight heparin(treatment group) or with low molecular weight heparin only(control group).Efficacy between the two groups were compared.Results In the treatment group,the cure ra...
Keywords:Urokinase  Low molecular weight heparin  Thrombolytic therapy  Cerebral hemorrhage  Deep vein thrombosis  Femoral artery  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号